The ADRD chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ADRD chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ADRD stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ADRD Detailed Price Forecast - CNN Money||View ADRD Detailed Summary - Google Finance|
|View ADRD Detailed Summary - Yahoo! Finance||View ADRD Stock Research & Analysis - Zacks.com|
|View ADRD Trends & Analysis - Trade-Ideas||View ADRD Major Holders - Barrons|
|View ADRD Call Transcripts - NASDAQ||View ADRD Breaking News & Analysis - Seeking Alpha|
|View ADRD Annual Report - CompanySpotlight.com||View ADRD OTC Short Report - OTCShortReport.com|
|View ADRD Fundamentals - TradeKing||View ADRD SEC Filings - Bar Chart|
|View Historical Prices for ADRD - The WSJ||View Performance/Total Return for ADRD - Morningstar|
|View the Analyst Estimates for ADRD - MarketWatch||View the Earnings History for ADRD - CNBC|
|View the ADRD Earnings - StockMarketWatch||View ADRD Buy or Sell Recommendations - MacroAxis|
|View the ADRD Bullish Patterns - American Bulls||View ADRD Short Pain Metrics - ShortPainBot.com|
|View ADRD Stock Mentions - StockTwits||View ADRD Stock Mentions - PennyStockTweets|
|View ADRD Stock Mentions - Twitter||View ADRD Investment Forum News - Investor Hub|
|View ADRD Stock Mentions - Yahoo! Message Board||View ADRD Stock Mentions - Seeking Alpha|
|View Insider Transactions for ADRD - SECform4.com||View Insider Transactions for ADRD - Insider Cow|
|View ADRD Major Holdings Summary - CNBC||View Insider Disclosure for ADRD - OTC Markets|
|View Insider Transactions for ADRD - Yahoo! Finance||View Institutional Holdings for ADRD - NASDAQ|
|View ADRD Stock Insight & Charts - FinViz.com||View ADRD Investment Charts - StockCharts.com|
|View ADRD Stock Overview & Charts - BarChart||View ADRD User Generated Charts - Trading View|
GlaxoSmithKline’s Vaccine Business in 1Q18
Posted on Monday April 30, 2018
GlaxoSmithKline’s (GSK) Vaccine business includes vaccines for meningitis, influenza, and shingles as well as established vaccines. GlaxoSmithKline had acquired meningitis vaccines from Novartis (NVS) in 2016.
Analysts’ Views on Sanofi, Pre-1Q18 Earnings Release
Posted on Wednesday April 25, 2018
In 1Q18, analysts expect Sanofi’s (SNY) revenue to fall ~6.6% YoY (year-over-year) to 8.1 billion euros from 8.7 billion euros, and its earnings per share to fall to 1.13 euros from 1.42 euros. Sanofi’s stock price has fallen ~9.4% over the last 12 months and ~7.1% year-to-date. Analysts’ price target of $47.67 suggests the stock could return ~19.2% over the next 12 months based on its price of $39.95 on April 23.
Novartis’s 1Q18 Estimates: Expectations for Alcon
Posted on Wednesday April 18, 2018
Alcon, Novartis’s (NVS) eye care business, includes surgical products and vision care products. Alcon products are marketed in over 180 countries worldwide. Alcon is expected to report growth in revenue following increased demand for contact lenses and surgical products in 1Q18.
What Analysts Recommend for AstraZeneca in March 2018
Posted on Wednesday March 14, 2018
As discussed earlier, AstraZeneca surpassed Wall Street analyst estimates for earnings per share (or EPS) and revenues and reported EPS of $1.03 on revenues of ~$5.8 billion in 4Q17, a 3% increase in revenues as compared to revenues of 4Q16. AstraZeneca’s stock price has increased by nearly 14.9% over the last 12 months but decreased by ~2.6% in 2018 year-to-date. Wall Street analysts have a 12-month target price of $39.09 per share as compared to the last price of $33.78 per share as of March 8, 2018.